Ketamin

Ketamine Hydrochloride, the active ingredient in Ketamin, is a dissociative anesthetic presented as a sterile injectable solution for intramuscular and intravenous use. It is employed for induction and maintenance of anesthesia, procedural sedation, acute pain control, and, in some settings, off‑label treatment of resistant depression.

GNH USA supplies Ketamin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU GMP standards and provides regulatory‑approved batches to procurement teams in diverse health‑care settings. All shipments are traceable and meet cold‑chain requirements where applicable.

Ketamine is a dissociative anesthetic that acts on the central nervous system via NMDA receptor antagonism.

- Induction and maintenance of anesthesia: provides rapid, controllable loss of consciousness for surgical procedures. - Procedural sedation: produces a calm, analgesic state for diagnostic or minor therapeutic interventions. - Acute pain management: offers potent analgesia for severe pain when other agents are insufficient. - Treatment‑resistant depression (off‑label): may alleviate depressive symptoms in patients unresponsive to conventional therapies.

Ketamine can cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness. - Nausea and vomiting. - Increased salivation. - Transient visual disturbances. - Elevated blood pressure. - Mild respiratory irritation.

Serious or Rare Side Effects: - Respiratory depression requiring airway support. - Emergence delirium or severe agitation. - Profound hypertension or cardiac arrhythmia. - Psychotic reactions or hallucinations. - Severe allergic response (anaphylaxis). - Persistent urinary tract symptoms with long‑term use.

Ketamine should be administered with careful clinical monitoring.

- Cardiovascular assessment: monitor blood pressure and heart rate before and during use. - Psychiatric screening: evaluate for history of psychosis or severe anxiety. - Intracranial pressure: avoid in patients with uncontrolled increased intracranial pressure. - Hepatic function: use cautiously in moderate to severe liver impairment. - Drug‑specific training: ensure personnel are trained in airway management and emergency resuscitation. - Store below 25°C: keep in original container, protect from light and moisture.

Ketamine may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Benzodiazepines: may potentiate sedation and respiratory depression. - Alcohol: additive central nervous system depression.

Moderate Interactions (Monitor Closely): - Opioids: additive analgesic effect and potential respiratory depression. - Sympathomimetics: may blunt expected cardiovascular responses. - Anticholinergics: could increase intra‑ocular pressure.